Pfizer Inc. (PFE) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Pfizer Inc.’s current trading price is -37.87% away from its 52-week high, while its distance from the 52-week low is 6.91%. The stock’s price range over this period has fluctuated between $25.76 and $44.33. The company, operating within the financial sector, had a trading volume of approximately 7.65 million for the day, which was noticeably lower than the average daily share volume of 46.35 million over the last 3 months.

Pfizer Inc.’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $44.33 on 02/14/23 and a low of $25.76 for the same time frame on 12/13/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Pfizer Inc. (PFE) has experienced a quarterly decline of -10.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 155.50B and boasts a workforce of 83000 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 29.89, with a change in price of -6.11. Similarly, Pfizer Inc. recorded 39,711,320 in trading volume during the last 100 days, posting a change of -18.18%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PFE stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.63.

PFE Stock Stochastic Average

Today, Pfizer Inc.’s raw stochastic average for the past 50 days stands at 37.16%, indicating a decline from the raw stochastic average of the last 20 days, which was 41.53%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 40.38% and 33.02% respectively.

PFE Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a loss of -4.34%.However, over the last six months, we can see a stronger performance of -22.90%. Over the last 30 days, the price of PFE has leaped by -5.00%. And in the last five days, it has surged by 2.27%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts